Hospital and Community Fluoroquinolone Use and Resistance in Staphylococcus aureus and Escherichia coli in 17 US Hospitals

Overview of attention for article published in Clinical Infectious Diseases, June 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

policy: 1 policy source

guideline: 2 clinical guideline sources

Readers on

mendeley: 96 Mendeley

So far, Altmetric has seen 2 Guidelines that reference this research output.

Update on a proper use of systemic fluoroquinolones in adult patients (ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, pefloxacin)

Clinical guideline published by French Infectious Diseases Society (SPILF) on 01 Sep 2015

The French Infectious Diseases Society (SPILF) is dedicated to advancing the field of infectious diseases through education, research, and clinical guidelines. Founded in 1973, it provides resources for healthcare professionals, including recommendations and training on antibiotic use and emerging infections.

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

Clinical guideline published by Center for International Blood and Marrow Transplant Research (CIBMTR) on 09 Sep 2009

The Center for International Blood and Marrow Transplant Research (CIBMTR) is a collaborative organization dedicated to advancing research in cellular therapies. It provides a comprehensive database and expert resources aimed at improving patient outcomes through innovative studies and data collection.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.